UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.265

Sortiert nach

Oncolytic viruses for cancer immunotherapy

Journal of hematology and oncology, 2020-06, Vol.13 (1), p.84-84, Article 84

2020

Link zum Volltext

Verfügbarkeit prüfen

Brazil: An Emerging Power Establishing Itself in the World of International Sports Mega-Events

International journal of the history of sport, 2014-07, Vol.31 (10), p.1312-1327

Santos, João Manuel Casquinha Malaia

2014

Link zum Volltext

Verfügbarkeit prüfen

Institutionalization of common land property in Portugal: Tragic trends between “Commons” and “Anticommons”

Land use policy, 2013-11, Vol.35, p.85-94

2013

Link zum Volltext

Verfügbarkeit prüfen

Ground vegetation as an indicator of site quality: effect of non-site factors on the productivity of newly established chestnut plantations in northwestern Spain

Journal of forest research, 2013-10, Vol.18 (5), p.407-417

2013

Link zum Volltext

Verfügbarkeit prüfen

Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer

Frontiers in immunology, 2022-03, Vol.13, p.794251-794251

2022

Link zum Volltext

Verfügbarkeit prüfen

Exploring the effect of land use on ecosystem services: The distributive issues

Land use policy, 2015-05, Vol.45, p.141-149

2015

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity

Journal for immunotherapy of cancer, 2020-01, Vol.8 (1), p.e000188

2020

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy

Molecular therapy. Oncolytics, 2017-03, Vol.4 (C), p.77-86

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition

Oncoimmunology, 2020-01, Vol.9 (1), p.1761229-1761229

2020

Link zum Volltext

Verfügbarkeit prüfen

CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy

Oncoimmunology, 2018-10, Vol.7 (10), p.e1490856-e1490856

2018

Link zum Volltext

Verfügbarkeit prüfen

Employing discrete global grid systems for reproducible data obfuscation

Scientific data, 2024-05, Vol.11 (1), p.509-509, Article 509

2024

Link zum Volltext

Verfügbarkeit prüfen

Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers

Diseases, 2022-08, Vol.10 (3), p.52

2022

Link zum Volltext

Verfügbarkeit prüfen

Sport and Authoritarianism in Latin America: An Introduction

International journal of the history of sport, 2022-12, Vol.39 (15), p.1585-1590

2022

Link zum Volltext

Verfügbarkeit prüfen

The multi-thermal chromosphere: Inversions of ALMA and IRIS data

Astronomy and astrophysics (Berlin), 2020-02, Vol.634, p.A56

2020

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the tumor microenvironment with an oncolytic adenovirus for effective T-cell therapy and checkpoint inhibition

Methods in enzymology, 2020, Vol.635, p.205

2020

Link zum Volltext

Verfügbarkeit prüfen

Rare vertebral metastasis in a case of Hereditary Paraganglioma

Hereditary cancer in clinical practice, 2012-09, Vol.10 (1), p.12-12, Article 12

2012

Link zum Volltext

Verfügbarkeit prüfen

First-in-human clinical trial of an oncolytic adenovirus armed with TNFa and IL-2 in patients with advanced melanoma receiving adoptive cell transfer of tumor-infiltrating lymphocytes

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS9590-TPS9590

2022

Link zum Volltext

Verfügbarkeit prüfen

806 Oncolytic adenovirus coding for human Mucin1 T cell engager with interleukin-2 potentiates anti-tumor T cell responses against tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A904-A904

2023

Link zum Volltext

Verfügbarkeit prüfen

805 Oncolytic adenovirus encoding human interleukin-7 in combination with ICIs as a treatment strategy against renal cell carcinoma (RCC)

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A903-A903

2023

Link zum Volltext

Verfügbarkeit prüfen

711 Development of oncolytic adenovirus Ad5/3-E2F-D24-hTNFa-IRES-hIL2 (TILT-123) for the treatment of solid tumours – from preclinical testing to phase I clinical trials

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A806-A806

2023

Link zum Volltext

Verfügbarkeit prüfen

814 Enhancing anti-tumor response in ICI-refractory non-small cell lung cancer through intravenous administration of oncolytic adenovirus armed with hTNFα and hIL-2 in combination with aPD-1 blockade

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A912-A912

2023

Link zum Volltext

Verfügbarkeit prüfen

Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy

International journal of cancer, 2017-10, Vol.141 (7), p.1458-1468

2017

Link zum Volltext

Verfügbarkeit prüfen

Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes

Cancer gene therapy, 2021-05, Vol.28 (5), p.442-454

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.265

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(899)
Mit Volltextzugriff
(1.153)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(631)
Life Sciences & Biomedicine
(462)
Humans
(296)
Male
(176)
Female
(165)
Technology
(158)
Engineering
(100)
Middle Aged
(88)
Adult
(83)
Adolescent
(79)
Physical Sciences
(73)
Biomedical Engineering
(64)
Portugal
(64)
Aged
(60)
Dentistry / Oral & Maxillofacial Medicine
(60)
Child
(56)
Computer Science
(55)
Cardiac & Cardiovascular Systems
(54)
Engineering, Biomedical
(52)
Cardiovascular System & Cardiology
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(19)
... seit 90 Tagen
(42)

Menü

Weitere Dienste

Einstellungen

Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting

Oncolytic viruses for cancer immunotherapy

Brazil: An Emerging Power Establishing Itself in the World of International Sports Mega-Events

Institutionalization of common land property in Portugal: Tragic trends between “Commons” and “Anticommons”

Ground vegetation as an indicator of site quality: effect of non-site factors on the productivity of newly established chestnut plantations in northwestern Spain

Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer

Exploring the effect of land use on ecosystem services: The distributive issues

Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity

Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition

CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy

Employing discrete global grid systems for reproducible data obfuscation

Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers

Sport and Authoritarianism in Latin America: An Introduction

Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression

The multi-thermal chromosphere: Inversions of ALMA and IRIS data

Modulation of the tumor microenvironment with an oncolytic adenovirus for effective T-cell therapy and checkpoint inhibition

Rare vertebral metastasis in a case of Hereditary Paraganglioma

First-in-human clinical trial of an oncolytic adenovirus armed with TNFa and IL-2 in patients with advanced melanoma receiving adoptive cell transfer of tumor-infiltrating lymphocytes

806 Oncolytic adenovirus coding for human Mucin1 T cell engager with interleukin-2 potentiates anti-tumor T cell responses against tumors

805 Oncolytic adenovirus encoding human interleukin-7 in combination with ICIs as a treatment strategy against renal cell carcinoma (RCC)

711 Development of oncolytic adenovirus Ad5/3-E2F-D24-hTNFa-IRES-hIL2 (TILT-123) for the treatment of solid tumours – from preclinical testing to phase I clinical trials

814 Enhancing anti-tumor response in ICI-refractory non-small cell lung cancer through intravenous administration of oncolytic adenovirus armed with hTNFα and hIL-2 in combination with aPD-1 blockade

Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy

Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes

Suchergebnisse filtern